| 1. |
Rappuoli, R. and Pizza, M. (1991) Structure and evolutionary aspects of ADP-ribosylating toxins, in Sourcebook of Bacterial Protein Toxins (Alouf, J. and Freer, J., eds.), Academic Press, New York, pp. 1–20.
|
| |
| 2. |
Telford, J. L., Ghiara, P., Dell’Orco, M., Comanducci, M., Burroni, D., Bugnoli M., et al. (1994) Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med.
179, 1653–1658.
|
| |
| 3. |
Ramon, G. (1924) Sur la toxine et sur’ anatoxine diphtheriques. Ann. Inst. Pasteur
38, 1–10.
|
| |
| 4. |
Rappuoli, R. (1997) New and improved vaccines against diphtheria and tetanus, in New Generation Vaccines (Levine, M. M., Woodrow, G. C., Kaper, J. B., and Cobon, G. S., eds.), Marcel Dekker, New York, pp. 251–268.
|
| |
| 5. |
Rappuoli, R. (1994) Toxin inactivation and antigen stabilization: two different uses of formaldehyde-short review. Vaccine
12, 579–581.
|
| |
| 6. |
Pizza, M., Covacci, A., Bartoloni, A., Perugini, M., Nencioni, L., De Magistris, M. T., et al. (1989) Mutants of pertussis
toxin suitable for vaccine development. Science
246, 497–500.
|
| |
| 7. |
Rappuoli, R., Podda, A., Pizza, M., Covacci, A., Bartoloni, A., De Magistris, M. T., et al. (1992) Progress towards the development
of new vaccines against whooping cough. Vaccine
10, 1027–1032.
|
| |
| 8. |
Podda, A., Deluca, E. C., Contu, B., Furlan, R., Maida, A., Moiraghi, A., et al. (1994) Comparative study of a whole-cell
pertussis vaccine and a recombinant acellular pertussis vaccine. J. Pediatr.
124, 921–926.
|
| |
| 9. |
Pizza, M., Domenighini, M., Hol, W., Giannelli, V., Fontana, M. R., Giuliani, M. M., et al. (1994) Probing the structure-activity
relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol. Microbiol.
14, 51–60.
|
| |
| 10. |
Pizza, M., Fontana, M. R., Giuliani, M. M., Domenighini, M., Magagnoli, C., Giannelli, V., et al. (1994) A genetically detoxified
derivative of heat-labile E. coli enterotoxin induces neutralizing antibodies against the A subunit. J. Exp. Med.
6, 2147–2153.
|
| |
| 11. |
Pizza, M., Giuliani, M. M., Fontana, M. R., Monaci, E., Douce, G., Dougan, G., et al. (2001) Mucosal vaccines: non toxic derivatives
of LT and CT as mucosal adjuvants. Vaccine
19, 2534–2541.
|
| |
| 12. |
Tamura, M., Nogimori, K., Katada, T., Ui, M., and Ishii, S. (1982) Subunit structure of islet-activating protein, pertussis
toxin, in conformity with the A-B model. Biochemistry
21, 5516–5520.
|
| |
| 13. |
Sixma, T. K., Pronk, S. E., Kalk, K. H., Wartna, E. S., van Zanten, B. A. M., Witholt, B., et al. (1991) Crystal structure
of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature
351, 371–377.
|
| |
| 14. |
Stein, P. E., Boodhoo, A., Armstrong, G. D., Cockle, S. A., Klein, M. H., and Read, R. J. (1994) The crystal structure of
pertussis toxin. Structure
2, 45–57.
|
| |
| 15. |
Domenighini, M., Montecucco, C., Ripka, W. C., and Rappuoli, R. (1991) Computer modeling of the NAD binding site of ADP-ribosylating
toxins: active site structure and mechanism of NAD binding. Mol. Microbiol.
5, 23–31.
|
| |
| 16. |
Domenighini, M., Magagnoli, C., Pizza, M., and Rappuoli, R. (1994) Common features of the NAD-binding and catalytic site of
ADP-ribosylating toxins. Mol. Microbiol.
14, 41–50.
|
| |
| 17. |
Nicosia, A., Perugini, M., Franzini, C., Casagli, M. C., Borri, M. G., Antoni, G., et al. (1986) Cloning and sequencing of
the pertussis toxin genes: operon structure and gene duplication. Proc. Natl. Acad. Sci. USA
83, 4631–4635.
|
| |
| 18. |
Locht, C. and Keith, J. M. (1986) Pertussis toxin gene: nucleotide sequence and genetic organization. Science
232, 1258–1264.
|
| |
| 19. |
Mekalanos, J. J., Swartz D. J., Pearson, G. D., Harford, N., Groyne, F., and de Wilde, M. (1983) Cholera toxin genes: nucleotide
sequence, deletion analysis and vaccine development. Nature
306, 551–557.
|
| |
| 20. |
Dallas, W. S. and Falkow, S. (1980) Amino acid homology between cholera toxin and Escherichia coli heat labile toxin. Nature
288, 499–501.
|
| |
| 21. |
Zoller, M. J. and Smith, M. (1982) Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general
procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res.
10, 6487–6500.
|
| |
| 22. |
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 68–73.
|
| |
| 23. |
Pittman, M. (1984) Genus Bordetella, in Bergey’s Manual of Systemic Bacteriology (Krief, N. R. and Holt, J. G., eds.), William and Wilkins, Baltimore, MD, pp. 338.
|
| |
| 24. |
Stainer, D. W. and Scholte, M. J. (1971) A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol.
63, 211–220.
|
| |
| 25. |
Stibitz, S. and Yang, M. S. (1991) Subcellular localization and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J. Bacteriol.
173, 4288–4291.
|
| |
| 26. |
Simon, R., Priefer, U., and Puhler, A. (1983) A broad host range mobilization system for in vivo genetic engineering: transposon
mutagenesis in gram-negative bacteria. BioTechnology
1, 784–791.
|
| |
| 27. |
Lebens, M., Johansson, S., Osek, J., Lindblad, M., and Holmgren, J. (1993) Large-scale production of Vibrio-cholerae toxin-B subunit for use in oral vaccines. BioTechnology
11, 1574–1578.
|
| |
| 28. |
Donta, S. T., Moon, H. W., and Whipp, S. C. (1973) Detection and use of heat-labile Escherichia coli enterotoxin with the use of adrenal cells in tissue culture. Science
183, 334–335.
|
| |
| 29. |
Hewlett, E. L., Sauer, K. T., Myers, G. A., Cowell, J. L., and Guerrant, R. (1983) Induction of a novel morphological response
in Chinese hamster ovary cells by pertussis toxin. Infect. Immun.
40, 1198–1203.
|
| |
| 30. |
Stibitz, S., Black, W., and Falkow, S. (1986) The construction of a cloning vector designed for gene replacement in Bordetella pertussis. Gene
50, 133–140.
|
| |
| 31. |
Pronk, S. E., Hofstra, H., Groendijk, H., Kingma, J., Swarte, M. B. A., Dorner, F., et al. (1985) Heat-labile enterotoxin
of Escherichia coli: characterization of different crystal forms. J. Biol. Chem.
260, 13,580–13,584.
|
| |
| 32. |
Pearson, G. D. N. and Mekalanos, J. J. (1982) Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA
79, 2976–2980.
|
| |
| 33. |
Dente, L., Cesarini, G., and Cortese, R. (1983) pEMBL: a new family of single stranded plasmids. Nucleic Acids Res.
11, 1645–1655.
|
| |
| 34. |
Fontana, M.R., Monaci, E., Liu, YQ., Qi, GM., Guangcai, D., Rappuoli, R., Pizza, M. (2001) IEM101, a naturally attenuated
Vibrio cholera strani as carrier for genetically detoxified derivatives of cholera toxin. Vaccine
19, 75–85.
|
| |
| 35. |
Donnenberg, M. S. and Kaper, J. K. (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Immun.
59, 4310–4317.
|
| |
| 36. |
Mekalanos, J. (1988) Production and purification of cholera toxin. Meth. Enzymol.
165, 169–175.
|
| |